Detalhe da pesquisa
1.
Phase I trial of antigen-targeted autologous dendritic cell-based vaccine with in vivo activation of inducible CD40 for advanced prostate cancer.
Cancer Immunol Immunother
; 66(10): 1345-1357, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28608115
2.
Absence of Replication-Competent Retrovirus in Vectors, T Cell Products, and Patient Follow-Up Samples.
Mol Ther
; 26(1): 6-7, 2018 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29301109
3.
Interleukin-15-armored GPC3-CAR T cells for patients with solid cancers.
Res Sq
; 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38645165
4.
Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells.
Clin Cancer Res
; 23(14): 3499-3509, 2017 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28183713
5.
SOCS1 downregulation in dendritic cells promotes memory T-cell responses.
Vaccine
; 26(8): 1128-35, 2008 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-18222020